US FDA expands use of Amgen, AstraZeneca's drug for sinus infection

Core Insights - The U.S. Food and Drug Administration has approved a new drug developed by Amgen and AstraZeneca for treating a type of chronic sinus infection [1] Company Summary - Amgen and AstraZeneca are the drugmakers behind the newly approved treatment for chronic sinus infections [1]